Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Georgia Tech researchers have developed biosensors with advanced sleuthing skills and the technology may revolutionize cancer detection ... the sensors are cell-free, there's a reduced risk ...

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release ...

Trusted resource of information on Cancer that includes articles, news, videos, animations, quizzes, calculators and drugs.

Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, ...

Now, however, it seems these repair processes can recognize when overwhelming damage has occurred (e.g., from radiotherapy), and instruct a cancer cell how to die. "When DNA damaged by radiation ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...